Aspyra Inc. (APYI) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Cotizando a $, Aspyra Inc. (APYI) es una empresa del sector Healthcare valorada en 0. La acción obtiene una puntuación de 52/100, una calificación moderada basada en 9 KPI cuantitativos.
Ultimo analisis: 18 mar 2026Aspyra Inc. (APYI) Resumen de Asistencia Médica y Tuberías
Aspyra Inc. delivers engineered workflow solutions, encompassing software, hardware, and professional services, to the healthcare sector, specifically targeting labs, clinics, and imaging centers. Founded in 1978, the company focuses on providing integrated solutions for laboratory and imaging workflows, operating within a competitive healthcare IT landscape.
Tesis de Inversión
Aspyra Inc. presents a focused play within the healthcare information services sector, offering specialized workflow solutions for labs and imaging centers. While the company's small market capitalization and OTC listing introduce inherent risks, its established presence since 1978 suggests a degree of stability. Key value drivers include the potential for increased adoption of its integrated software and hardware solutions by healthcare providers seeking to improve operational efficiency. However, the company's negative profit margin of -60.9% raises concerns about its financial sustainability. The beta of -51.48 indicates an inverse correlation with the market, which may offer diversification benefits but also reflects potential business-specific risks. Investors should closely monitor Aspyra's ability to achieve profitability and manage its cost structure.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Aspyra Inc. operates in the healthcare information services sector, providing specialized workflow solutions for labs and imaging centers.
- The company was founded in 1978, indicating a long-standing presence in the healthcare IT market.
- Aspyra's solutions include software, interfaces, hardware, and professional services, offering an integrated approach to healthcare workflows.
- The company serves a diverse clientele, including specialty labs, reference labs, clinics, hospitals, imaging centers, and orthopedic practices.
- Aspyra Inc. has a negative profit margin of -60.9%, highlighting the need for improved financial performance.
Competidores y Pares
Fortalezas
- Long-standing presence in the healthcare IT market.
- Integrated solutions encompassing software, hardware, and services.
- Focus on specialized laboratory and imaging workflows.
- Established customer base across various healthcare settings.
Debilidades
- Negative profit margin indicating financial challenges.
- Small market capitalization and OTC listing posing liquidity risks.
- Limited brand recognition compared to larger competitors.
- Dependence on a niche segment of the healthcare IT market.
Catalizadores
- Upcoming: Potential partnerships with larger healthcare providers to expand market reach.
- Ongoing: Continued development and enhancement of existing software and hardware solutions.
- Ongoing: Efforts to improve operational efficiency and reduce costs.
Riesgos
- Potential: Negative profit margin and financial instability.
- Potential: Limited liquidity due to OTC listing.
- Ongoing: Intense competition from larger and more established players.
- Potential: Evolving regulatory requirements and technological advancements.
- Potential: Cybersecurity threats and data privacy concerns.
Oportunidades de crecimiento
- Expansion into Telehealth Solutions: Aspyra can leverage its existing expertise in healthcare IT to develop and offer telehealth solutions, capitalizing on the growing demand for remote patient monitoring and virtual consultations. The telehealth market is projected to reach $55.6 billion by 2027, presenting a significant opportunity for Aspyra to diversify its revenue streams and expand its customer base. Timeline: 1-2 years.
- Strategic Partnerships with Healthcare Providers: Aspyra can forge strategic partnerships with hospitals, clinics, and other healthcare providers to integrate its workflow solutions into their existing systems. These partnerships can provide Aspyra with access to a larger customer base and enhance its market visibility. Timeline: Ongoing.
- Development of AI-Powered Diagnostic Tools: Aspyra can invest in the development of artificial intelligence (AI)-powered diagnostic tools to enhance the capabilities of its imaging solutions. AI-powered diagnostics can improve the accuracy and speed of image analysis, leading to better patient outcomes and increased efficiency for healthcare providers. Timeline: 2-3 years.
- Geographic Expansion into Emerging Markets: Aspyra can expand its operations into emerging markets, where there is a growing demand for healthcare IT solutions. These markets offer significant growth potential due to increasing healthcare spending and a lack of established players. Timeline: 3-5 years.
- Focus on Cybersecurity Solutions for Healthcare: With the increasing threat of cyberattacks on healthcare organizations, Aspyra can develop and offer cybersecurity solutions specifically tailored for the healthcare industry. This can help healthcare providers protect sensitive patient data and ensure the integrity of their systems. Timeline: 1-2 years.
Oportunidades
- Expansion into telehealth solutions.
- Strategic partnerships with healthcare providers.
- Development of AI-powered diagnostic tools.
- Geographic expansion into emerging markets.
Amenazas
- Intense competition from larger and more established players.
- Evolving regulatory requirements and technological advancements.
- Cybersecurity threats and data privacy concerns.
- Economic downturns impacting healthcare spending.
Ventajas competitivas
- Established presence in the healthcare IT market since 1978.
- Integrated solutions offering a comprehensive approach to healthcare workflows.
- Specialized expertise in laboratory and imaging workflows.
Acerca de APYI
Aspyra Inc., established in 1978 and headquartered in Jacksonville, Florida, operates within the healthcare sector, providing a range of products and services tailored for the laboratory and imaging marketplaces. Originally named Creative Computer Applications Inc., the company rebranded as Aspyra Inc. in 2005 to better reflect its focus on integrated healthcare solutions. Aspyra's core offerings include engineered workflow solutions comprising software, interfaces, hardware, and professional services. These solutions are designed to optimize operations for a diverse clientele, including specialty labs, reference labs, clinics, hospitals, imaging centers, and orthopedic practices. The company's products facilitate efficient data management, streamlined workflows, and enhanced diagnostic capabilities within these healthcare settings. Aspyra's integrated approach aims to improve patient care and operational efficiency for its clients. With a history spanning over four decades, Aspyra has evolved to meet the changing needs of the healthcare industry, focusing on providing comprehensive solutions that address the specific challenges faced by laboratories and imaging centers. The company's commitment to innovation and customer satisfaction has allowed it to maintain a presence in the competitive healthcare IT market.
Qué hacen
- Provides healthcare products and services for the laboratory and imaging marketplaces.
- Offers engineered workflow solutions that include software.
- Provides hardware solutions for labs and imaging centers.
- Offers professional services to support its products.
- Serves specialty labs, reference labs, clinics, and hospitals.
- Caters to imaging centers and orthopedic practices.
Modelo de Negocio
- Sells integrated software and hardware solutions to healthcare providers.
- Generates revenue through professional services, including implementation and support.
- Focuses on recurring revenue through software maintenance and upgrades.
Contexto de la Industria
Aspyra Inc. operates within the healthcare information services industry, a sector experiencing growth driven by the increasing adoption of digital health solutions and the need for improved efficiency in healthcare workflows. The market is competitive, with established players and emerging startups vying for market share. Aspyra's focus on providing integrated solutions for labs and imaging centers positions it within a niche segment of the broader healthcare IT market. The industry is characterized by evolving regulatory requirements, technological advancements, and a growing emphasis on data security and interoperability.
Clientes Clave
- Specialty labs
- Reference labs
- Hospitals and clinics
- Imaging centers
- Orthopedic practices
Finanzas
Gráfico e información
Precio de la acción de Aspyra Inc. (APYI): Price data unavailable
Últimas noticias
No hay noticias recientes disponibles para APYI.
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para APYI.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para APYI.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de APYI en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Liderazgo: Gary W. Bennett
CEO
Gary W. Bennett serves as the CEO of Aspyra Inc., leading the company's strategic direction and overseeing its operations. His background includes experience in managing technology-driven businesses and driving growth in the healthcare IT sector. With a focus on innovation and customer satisfaction, Bennett is responsible for guiding Aspyra's efforts to provide integrated workflow solutions for laboratories and imaging centers. His leadership is crucial in navigating the competitive healthcare IT landscape and ensuring the company's long-term success.
Historial: Under Gary W. Bennett's leadership, Aspyra Inc. has focused on maintaining its position in the healthcare IT market by providing specialized solutions for labs and imaging centers. Key milestones include the continued development and enhancement of the company's software and hardware offerings. His tenure has been marked by efforts to improve operational efficiency and expand the company's customer base.
Información del mercado OTC de APYI
The OTC Other tier represents the lowest tier of the OTC market, encompassing stocks that may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, and trading activity can be sporadic. Investing in OTC Other stocks carries a higher degree of risk compared to stocks listed on major exchanges like the NYSE or NASDAQ due to the potential for less transparency and regulatory oversight.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited financial disclosure and transparency.
- Low trading volume and liquidity.
- Potential for price manipulation and fraud.
- Higher risk of business failure or delisting.
- Limited regulatory oversight and investor protection.
- Verify the company's legal status and registration.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the risks associated with the OTC Other tier.
- Consult with a qualified financial advisor.
- Check for any regulatory actions or legal proceedings.
- Established presence in the healthcare IT market since 1978.
- Focus on providing specialized solutions for labs and imaging centers.
- Existence of a functional website and contact information.
- Leadership team with relevant industry experience.
- Positive customer testimonials or case studies (if available).
Lo Que los Inversores Preguntan Sobre Aspyra Inc. (APYI)
¿Cuáles son los factores clave para evaluar APYI?
Aspyra Inc. (APYI) actualmente tiene una puntuación IA de 52/100, indicando puntuación moderada. Fortaleza clave: Long-standing presence in the healthcare IT market.. Riesgo principal a monitorear: Potential: Negative profit margin and financial instability.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de APYI?
APYI actualmente puntúa 52/100 (Grado C) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de APYI?
Los precios de APYI se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre APYI?
La cobertura de analistas para APYI incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en APYI?
Las categorías de riesgo para APYI incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Negative profit margin and financial instability.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de APYI?
La relación P/E para APYI compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está APYI sobrevalorada o infravalorada?
Determinar si Aspyra Inc. (APYI) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de APYI?
Aspyra Inc. (APYI) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Limited financial information available due to OTC listing.
- AI analysis pending for APYI.